Standard BioTools Inc. (LAB)
USD 1.99
(-10.18%)
USD 1.99
(-10.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -43.28 Million | -89.37 Million | -44.06 Million | -15.41 Million | -35.21 Million | -25.2 Million |
| Net Income | -74.65 Million | -190.09 Million | -59.23 Million | -53.02 Million | -64.79 Million | -59.01 Million |
| Depreciation & Amortization | 15.18 Million | 15.02 Million | 15.57 Million | 15.92 Million | 15.8 Million | 16.57 Million |
| Deferred income taxes | 6.28 Million | - | 21 Thousand | 212 Thousand | 12.55 Million | 141 Thousand |
| Stock-based compensation | 13.12 Million | 14.88 Million | 16.1 Million | 14.45 Million | 11.39 Million | 11.02 Million |
| Change in working capital | 1.78 Million | -15.48 Million | -19.93 Million | 2.41 Million | -13.23 Million | -2.47 Million |
| Other non-cash items | -5 Million | 86.3 Million | 3.41 Million | 4.6 Million | 3.06 Million | 8.55 Million |
| Investing Cash Flow | 20.23 Million | -88.12 Million | -11.94 Million | 39.97 Million | -39.3 Million | 4.71 Million |
| Investments in PPE | -2.83 Million | -3.82 Million | -13.26 Million | -12.71 Million | -2.53 Million | -372 Thousand |
| Acquisitions | -23.06 Million | 84.3 Million | - | -5.15 Million | 36.77 Million | - |
| Investment purchases | -94.89 Million | -137.3 Million | - | - | -62.37 Million | -1.45 Million |
| Sales/Maturities of investments | 117.96 Million | 53 Million | - | 36.81 Million | 25.6 Million | 6.54 Million |
| Other Investing Activities | 23.06 Million | -84.3 Million | 1.31 Million | 21.03 Million | -36.77 Million | 5.09 Million |
| Financing Cash Flow | -6.8 Million | 230.75 Million | 15.95 Million | 20.85 Million | 2.79 Million | 57.66 Million |
| Debt repayment | -2.08 Million | -18.16 Million | -501 Thousand | - | -51.82 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.41 Million | -563 Thousand | -1.79 Million | -459 Thousand | -629 Thousand | -358 Thousand |
| Common Stock Issuance | 827 Thousand | 225.91 Million | 1.49 Million | 20.22 Million | 2.13 Million | 59.46 Million |
| Other Financing Activities | -139 Thousand | -12.75 Million | 17.05 Million | 1.09 Million | 54.61 Million | -1.8 Million |
| Accounts receivables | -2.99 Million | 1.06 Million | 6.72 Million | -7.62 Million | -2.07 Million | -1.78 Million |
| Accounts payables | 1.61 Million | -2.77 Million | 1.28 Million | 3.35 Million | 2.14 Million | -294 Thousand |
| Inventory | -4.91 Million | -8.47 Million | -4.78 Million | -8.63 Million | -2.68 Million | 1.48 Million |
| Other working capital | 8.07 Million | -5.29 Million | -23.16 Million | 15.32 Million | -10.62 Million | -1.88 Million |
| Cash at beginning of period | 81.32 Million | 29.46 Million | 69.53 Million | 23.73 Million | 95.4 Million | 58.05 Million |
| Cash at end of period | 51.7 Million | 82.32 Million | 29.46 Million | 69.53 Million | 23.73 Million | 95.4 Million |
| Capital Expenditure | -2.83 Million | -3.82 Million | -13.26 Million | -12.71 Million | -2.53 Million | -372 Thousand |
| Effect of forex changes on cash | 34 Thousand | -404 Thousand | -21 Thousand | 385 Thousand | 56 Thousand | 167 Thousand |
| Net cash flow / Change in cash | -29.62 Million | 52.85 Million | -40.06 Million | 45.8 Million | -71.66 Million | 37.34 Million |
| Free Cash Flow | -46.11 Million | -93.19 Million | -57.32 Million | -28.13 Million | -37.74 Million | -25.57 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.93 Million | -45.71 Million | -32.15 Million | -19.77 Million | -74.65 Million | -20.99 Million |
| Depreciation & Amortization | -5.51 Million | 3.85 Million | 5.19 Million | 3.9 Million | 15.18 Million | 3.98 Million |
| Deferred income taxes | - | - | - | -14.5 Million | 6.28 Million | 391 Thousand |
| Stock-based compensation | 5.92 Million | 6.73 Million | 11.61 Million | 3.47 Million | 13.12 Million | 3.38 Million |
| Change in working capital | 26.52 Million | -4.02 Million | -22.49 Million | -1.6 Million | 1.78 Million | 1.69 Million |
| Other non-cash items | -27.85 Million | 17.08 Million | 13.29 Million | 14.45 Million | -5 Million | 131 Thousand |
| Investing Cash Flow | -30.88 Million | 50.25 Million | 318.07 Million | -13.11 Million | 20.23 Million | -49.92 Million |
| Investments in PPE | -2.25 Million | -1.93 Million | -781 Thousand | -78 Thousand | -2.83 Million | -905 Thousand |
| Acquisitions | -560.06 Million | 280.03 Million | 280.03 Million | 13.03 Million | -23.06 Million | - |
| Investment purchases | -78.62 Million | -74.8 Million | -73.17 Million | -39.03 Million | -94.89 Million | -49.02 Million |
| Sales/Maturities of investments | 50 Million | 127 Million | 112 Million | 26 Million | 117.96 Million | - |
| Other Investing Activities | 560.06 Million | 52.19 Million | 280.03 Million | -13.03 Million | 23.06 Million | -49.02 Million |
| Financing Cash Flow | -2000.00 | -28.36 Million | -19.73 Million | -1 Million | -6.8 Million | -1.16 Million |
| Debt repayment | -8.73 Million | - | -8.73 Million | -1.25 Million | -2.08 Million | -833 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -29.43 Million | -11.05 Million | -174 Thousand | -5.41 Million | -399 Thousand |
| Common Stock Issuance | -1.47 Million | 1.4 Million | 72 Thousand | 421 Thousand | 827 Thousand | 80 Thousand |
| Other Financing Activities | 10.21 Million | -327 Thousand | -17 Thousand | 1.00 | -139 Thousand | 68 Thousand |
| Accounts receivables | -5.01 Million | 4.32 Million | 686 Thousand | -3.66 Million | -2.99 Million | -1.56 Million |
| Accounts payables | 10.69 Million | -410 Thousand | -10.28 Million | 2.1 Million | 1.61 Million | 1.29 Million |
| Inventory | 12.77 Million | -6.44 Million | -6.32 Million | -1.65 Million | -4.91 Million | -1.31 Million |
| Other working capital | 8.06 Million | -1.49 Million | -6.57 Million | 1.61 Million | 8.07 Million | 3.28 Million |
| Cash at beginning of period | 269.81 Million | 287.05 Million | 51.7 Million | 79.65 Million | 81.32 Million | 143.09 Million |
| Cash at end of period | 211.93 Million | 269.81 Million | 287.05 Million | 51.7 Million | 51.7 Million | 80.45 Million |
| Capital Expenditure | -2.25 Million | -1.93 Million | -781 Thousand | -78 Thousand | -2.83 Million | -905 Thousand |
| Effect of forex changes on cash | -408 Thousand | -89 Thousand | -21 Thousand | 230 Thousand | 34 Thousand | -147 Thousand |
| Net cash flow / Change in cash | -57.87 Million | -17.24 Million | 235.35 Million | -27.95 Million | -29.62 Million | -62.64 Million |
| Free Cash Flow | -30.12 Million | -40.98 Million | -63.25 Million | -14.13 Million | -46.11 Million | -12.31 Million |
MFI
VZUG
041510
6559
OPT
IDFCFIRSTB